TORONTO, June 6, 2019 /CNW/ – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV:PCLO), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., today announced that it has entered into a scheme implementation agreement (the “Implementation Agreement”) pursuant to which PharmaCielo has agreed to acquire all of the issued and outstanding shares and listed options of Creso Pharma Ltd. (“Creso Pharma”) (ASX:CPH), for an aggregate purchase price of approximately A$122 million (the “Acquisition”). Creso Pharma is a global medicinal cannabis company that specializes in research, development and production of therapeutic, nutraceutical and animal health products. PharmaCielo will pay A$0.63 per Creso Pharma share, representing a premium of 50% over the closing trading price of the Creso Pharma shares on May 31, 2019. The purchase price for the Creso Pharma shares will be satisfied by the issuance of PharmaCielo common shares (“PharmaCielo Shares”) priced at C$7.6166 per PharmaCielo Share being the 3-day volume weighted average trading price for the PharmaCielo Shares representing an exchange ratio of a 0.0775 PharmaCielo Shares per each Creso Pharma share.
Technology Leader Leverages its Proprietary Data to Provide Evidence-based Research Reports to the Cannabis Industry
NEW YORK, June 6, 2019 /PRNewswire/ — As the Canadian cannabis market continues to mature, the consumer market is expected to witness a proliferation of edibles and other alternative cannabis-based products. Alternative products have become increasingly popular over recent years as consumers continue to stray away from traditional flower. Now shoppers are opting towards products such as concentrates and extracts, which are considered much more potent and cleaner when compared to smoking flower. Emerging products are expected to deliver annual revenue of more than CAD 2.5 Billion and generate higher profits for retailers than cannabis products that are already legal, according to Deloitte’s annual cannabis industry report. In addition to new products, Deloitte mentions other growth drivers such as the introduction of the alcohol and tobacco industry, mergers and acquisitions, and the entry of pharmaceutical companies. However, Deloitte is also forecasting that edibles are expected to be the primary growth driver for the overall Canadian market, as edible and alternative cannabis-based products are expected to account for CAD 1.6 Billion of the total CAD 2.5 Billion marketplace. Infused beverages (CAD 529 Million), topicals (CAD 174 Million), concentrates (CAD 140 Million, tinctures (CAD 116 Million), and capsules (114 Million) also make it on the list. In combination, the global market for alternative products is expected to double over the next five years, reaching USD 194 Billion. And while the U.S. marketplace accounts for a majority of the global market share, Deloitte highlights that Canada is better positioned than the U.S. The firm notes that Canadian-based cannabis companies receive significant advantages over its global counterparts, such as government support, access to capital markets and the banking system, as well as a unified market. As a result, the U.S. is expected to see its market share dwindle as more global players enter into the cannabis industry. Nonetheless, the U.S. market is still expected to thrive, especially after the passage of the U.S. Farm Bill last year. Pasha Brands Ltd. (CSE: CRFT, Walgreens Boots Alliance, Inc. (NASDAQ: WBA), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX: TGOD), Auxly Cannabis Group Inc. (OTC: CBWTF) (TSX-V: XLY)
NEW YORK, June 6, 2019 /PRNewswire/ — Technology has become prominent in almost every aspect of daily life for most consumers in the West. Even though technology has had a widespread impact, it continues to penetrate into other regions across the world as more and more consumers adapt to the digital era. It has become apparent in most global industries that the use of technology is required in order to thrive among the competition. For instance, major markets such as retailers, banks, healthcare, and even the food industry have incorporated technology in order to operate more efficiently and effectively. For instance, retailers and banks introduced digital payment portals to speed up the transaction process of payments, while the food industry created mobile apps so consumers can order remotely. Meanwhile, the healthcare industry integrated advanced technology to accurately diagnose and operate on patients. Moreover, one industry that has benefitted from the evolution of technology is the cannabis market. Tech entrepreneurs and investors are eager to introduce ideas such as blockchain into the market space. Notably, verification and tracking systems have become highly popular across various cannabis segments because companies can track their product from seed-to-sale. Seed-to-sale verification keeps a transparent process between both the vendor and the consumer. Furthermore, The Verge reported that advanced technological applications such as machine learning and automation are becoming increasingly popular within the cannabis industry. For example, a Massachusetts-based company, Bloom Automation, has developed a robot that can automate the cannabis trimming process, eliminating the need for humans. Technology remains one of the key aspects to a successful business and as more companies shift towards technology, the cannabis industry has the potential to become the next disruptive global market. According to data compiled by MarketsandMarkets research, the global cannabis market is projected to grow from USD 10.3 Billion in 2018 to USD 39.4 Billion by 2023. Additionally, the market is expected to register a CAGR of 30.7% during the forecast period. Trutrace Technologies Inc. (OTC: BKKSF) (TSX-V: TTT), Emerald Health Therapeutics Inc. (OTC: EMHTF) (TSX-V: EMH), The Supreme Cannabis Company, Inc. (OTC: SPRWF) (TSX: FIRE), Terra Tech Corp. (OTC: TRTC), NightFood Holdings, Inc. (OTC: NGTF)
SPOKANE, Wash., June 6, 2019 /PRNewswire/ — Endoca, the leader of organic cannabis products, today announces its strategic move to join forces with Tough Mudder as its official CBD partner and sponsor. With participants from around the world, this obstacle-course focused event harnesses everyone from weekend warriors at their 5Ks to athletes at the top of their game as part of the competitive events. At Tough Mudder’s 2019 North America and United Kingdom events, Endoca will provide CBD education and product samples to participants.
OTTAWA, June 6, 2019 /CNW/ – CannaRoyalty Corp. d/b/a Origin House (the “Company” or “Origin House”) (CSE: OH and OTCQX: ORHOF) announces today that it has agreed with Cresco Labs Inc. (“Cresco”) to certain technical amendments (the “Amendments”) to its previously announced plan of arrangement (the “Arrangement”) pursuant to which Cresco will acquire all of the issued and outstanding shares of Origin House. The agreement amending the Arrangement (which includes the amended Plan of Arrangement) will be filed under the Company’s profile on www.sedar.com. The Amendments permit outstanding restricted share units (the “RSUs”) to remain outstanding following the completion of the Arrangement as opposed to automatically converting such RSUs into Subordinated Voting Shares of Cresco, as previously provided in the Plan of Arrangement. The Amendments were agreed to as they provide additional flexibility to holders of the RSUs without effect to the treatment of Origin House’s shareholders under the Arrangement.
PALM BEACH, Florida, June 6, 2019 /PRNewswire/ — According to a recent industry article published this year, Jefferies analysts, after initiating coverage on the cannabis markets, followed up with additional coverage specific to the CBD industry and in particular CBD beauty products. The article suggests Jefferies believes the CBD beauty market could reach $25 Billion globally in the next 10 years and could even amass 15 percent of the total skincare market. The incredible potential of the CBD beauty market is thought to be enormous, given the possibility that many products could be sold over the counter and without the need for a prescription, clearly allowing consumers access to the products easily. CBD beauty products have quickly become all the rage now that industry analysts estimate it could be an entirely separate category from both recreational and medical marijuana. That’s opening a wide range of opportunity for companies including The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF), Aleafia Health (TSX-V:ALEF) (OTC:ALEAF), Curaleaf Holdings Inc. (CSE:CURA) (OTC:CURLF), and Westleaf Inc. (TSX-V:WL) (OTC:WSLFF).
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations
NEW YORK, June 6, 2019 /PRNewswire/ — Virtual Investor Conferences and KCSA Strategic Communications today announced that the presentations from the June 4(th) Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com.
ST. LOUIS, June 6, 2019 /PRNewswire/ — Purpl Scientific announced today that, after several years in development and a successful beta test, the Company has launched its groundbreaking portable cannabis potency testing solution to the world. Named the Purpl PRO, the device brings unprecedented mobility, insight and limitless lab-accurate THC and CBD tests to a market with a glaring need for transparency and accountability. The Purpl PRO is available for sale through authorized distributors for $1,495.